Test Code HEP ACUTE Acute Hepatitis Panel
Additional Codes
LAB551
Collection Method
Venous collection
Minimum Volume
8ml
Container
Gold Top SST
Acceptable Specimens
Gold Top SST
Reference or Target Ranges
Hepatitis A Antibody IgM (HAV M) | Nonreactive |
Hepatitis B Core Antibody IgM (HBcAb M) | Nonreactive |
Hepatitis B Surface Antigen (HBsAg) | Nonreactive |
Hepatitis C Antibody (HCV) with reflex | Nonreactive |
Reasons for Rejection
Hemolysis Threshold | See individual assays |
Icterus Threshold | See individual assays |
Lipemia Threshold | See individual assays |
Other | QNS, contaminated, improperly Labeled, improper specimen type |
Specimen Stability
Ambient | See individual assays |
Refrigerated (4°C to 8°C) | See individual assays |
Frozen(-40°C to 0°C) | See individual assays |
Performance Information
Days and Time Performed | 24/7 |
Expected Turn Around Time |
Stat: 1 hour Routine: 4 hours |
Stat Availability | Yes |
Performing Bench | CPH Chemistry |
Methodology/Method Description | Roche Cobas |
Result Interpretation
Hepatitis A Antibody IgM (HAV M) | |
Nonreactive | IgM antibodies to Hepatitis A Virus were not detected. This does not exclude the possibility of exposure to, or infection with HAV. Levels of IgM antibodies to HAV may be below the cut-off in early infection. |
Borderline | IgM antibodies to Hepatitis A may or may not be present. Patients exhibiting borderline test results should be closely monitored by redrawing and retesting at approximately two week intervals. |
Reactive | IgM antibodies to Hepatitis A Virus detected. This is presumptive evidence of HAV infection. A Reactive IgM antibody to HAV does not rule out other hepatitis infections. |
Hepatitis B Core Antibody IgM (HBcAb M) | |
Nonreactive | IgM antibodies to Hepatitis B Core were not detected. This does not exclude the possibility of prior exposure to, or infection with hepatitis. Levels of antibodies to hepatitis B core may be below the cut-off in early infection. |
Reactive | IgM antibodies to Hepatitis B core detected. This is presumptive evidence of acute infection or acute attack in an individual with chronic hepatitis B infection. A Reactive hepatitis B core antibody does not rule out other hepatitis infections. The specimen will be forwarded to Mayo Medical Laboratories for confirmatory testing. |
Hepatitis B Surface Antigen (HBsAg) | |
Nonreactive | Hepatitis B surface antigen was not detected. This does not exclude the possibility of exposure to, or infection with Hepatitis B Virus. |
Reactive | This test is intended as a screen only. A reactive result indicates presumptive evidence of infection with HBV. The specimen will be forwarded to Mayo Medical Laboratories for confirmatory testing. Specimens with reactive screen results but negative (ie, not confirmed) HBsAg confirmatory test results are likely to contain cross-reactive antibodies from other infectious or immunologic disorders. Repeat testing is recommended at a later date if clinically indicated. |
Hepatitis C Antibody (HCV) with reflex | |
Nonreactive | Antibodies to HCV were not detected; this does not exclude the possibility of exposure to HCV. |
Reactive | This test is intended as a screen only. A reactive result indicates presumptive evidence of antibodies to HCV. The specimen will be forwarded to Mayo Medical Laboratories for confirmatory testing. |
CPT Codes
80074
Last review/edit date
2025